RIGL

Rigel Pharmaceuticals Inc

• Reuters·1d ago

  Rigel grants 8,925 inducement RSUs to six new employees under NASDAQ rule 5635(c)(4)

• PR Newswire·1d ago

  Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

• Reuters·5d ago

  Rigel Pharmaceuticals announces annual shareholder meeting

• TipRanks·6d ago

  Rigel Pharmaceuticals Balances Breakout Growth With Caution

• Reuters·03/31 21:44

  Rigel says final ARROW data show 70% response rate for GAVRETO in RET+ NSCLC

• Benzinga·03/31 14:51

  FDA Adverse Event Monitoring System Q4 2025 Flags Multiple Potential New Drug Safety Signals, Including Hypersensitivity, Hypogammaglobulinemia, Colitis, Aplastic Anemia And Rhabdomyolysis Under Evaluation

• TipRanks·03/31 14:30

  Analysts Are Bullish on Top Healthcare Stocks: Palisade Bio (PALI), Rigel (RIGL)

• Benzinga·03/31 12:21

  Rigel Pharmaceuticals Publishes Final Data From Phase 1/2 ARROW Trial Of Pralsetinib To Treat Metastatic Rearranged During Transfection Fusion-Positive Non-Small Cell Lung Cancer

• TipRanks·03/31 12:14

  Rigel Pharmaceuticals’ pralsetinib shows efficacy in NSCLC clinical trial

• PR Newswire·03/31 12:05

  Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology

• Seeking Alpha·03/26 16:12

  Top 10 undervalued small-cap stocks with high growth grades

• TipRanks·03/20 16:31

  Rigel’s New Olutasidenib Interaction Study Signals Long-Game Strategy for RIGL Investors

• Reuters·03/10 20:15

  Rigel Pharmaceuticals publishes corporate presentation on commercial product sales growth and development pipeline expansion

• Seeking Alpha·03/10 10:49

  Rigel Pharmaceuticals: Growing Where It Matters

• Simply Wall St·03/07 11:21

  Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results